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Th© abthty of D.6.d¢oxy.nl)c).moshol 1,4,$.tnsphosphate [6.d¢oxy.lns(I,4,5)Pj], a ,~yntheuc analogue of the y~-~ond mesSenller D.mlo-lnusaol 
1.4,:S.tr=sphosphat¢ [Inq 1,4.5)P)], to mohhs¢ mtracellular Ca =° stores m permc.=bil,sed SH.SYSY neuroblastoma cells v,a= i,tvestlgated, 6.Deoxy. 
ins(I,4,~,)P, was a full against (ECso .. 6 4/IM), but was some "/0.fidd lea potent than Ins (I,4,$)P~ (ECv, .. 0 09 FM), md=~tmg chat the 6.hydroxyl 
group of Ins(I,4,~)P~ ~s important for receptor binding and )ttmulatten or ca =" release, but is not an essentml structural feature 6,Denny. 
[n$(I,4,.~)P.= was not a sulks=rate for Ins (I,4,5)Pz 5.phosphate=e, but ,nh)blted both the hydrolys=s of 5.p=P]+lns (I,4,5)P~ (K, "/6/d~t) and the 
phosphor~lat,on of pl'lllns(I,4,~i)P= Capparent g', 5 '7/~M) 6.Dcoxy.Ins (I,4,:S)P= ntobd=zed Ca =" w=th d,fferent k~neti¢~ to Ins(l,4,~)P.~, ind~=ttmg 
that It is prob,=bly a substrate for Ins (I.4,5}P= 3.km,tse 
Second mes~nller, Inos=tol phosphate ,inalogu¢, C~L =* mobths.tt~on 
l, INTRODUCTION 
D-myo-inositol 1,4,5-trisphosphate (ins(l,4,S)P), 
(1), Ftg. 1) ts recognised as a second messenger which 
mediates the release of sequestered Ca =* from m- 
traceilular stores [i,2]. Recent stud,es have led to the 
punficatmn [3], cloning and sequencing of the 
Ins(l,4,5)P3 receptor [4,5], which when incorporated 
into liposomes can mediate Ca =* release m response to 
lns(l,4,5)P~ [6] A major challenge ts now the elucida- 
tion of molecular aspects of the interaction of 
lns(l,4,5)P3 with ~ts receptor and with the enzymes in- 
volved m its metabolism, i.e. Ins(l,4,5)Pa 3-ki,mse and 
5-phosphatase, and the chemical design of novel 
lns(l,4,5)P3 agomsts, antagonists and enzyme m- 
h~bltors. Recent progress m inositol phosphate 
chemistry [7,8] and the molecular recogmtion of 
Ins(l,4,5)P3 by these three proteins has been revzewed 
[9]. 
In the absence of structural information on the 
Ins(l,4,5)P3 receptor, chemical modificatmn of the se- 
cond messenger molecule is an approach to probe 
molecular interactions. Several inositol ring-modified 
and phosphate-modified analogues have already been 
synthesized [']-17] and some progress has been made m 
understandlng the role of the three phosphate and 
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hydroxyl groups of Ins(l,4,S)P~ in determtmng recep- 
tor binding specificity and st~mulat,on of Ca =' release. 
As yet, however, little structure-activity data have 
emerged, apart from recognition of the fundamental 
importance of the vicinaI D-4,S-btsphosphat¢ moiety 
[8,9]. We report here a study on the interaction of the 
synthetic analogue D-6.deoxy-myo mosstol 
1,4,5-tnsphosphate (6-deoxy-lns(l,4,5)P3, (2), Fig. 1) 
with the Ca z~" releasing lns(1,4,5)Pa receptor of 
permeabihsed SH-SY5Y neuroblastoma cells and wsth 
rat brain Ins(1,4,5)Pa 3-kinase and human erythrocyte 
membrane Ins(l,4,5)P3 5-phosphatase. 
2. MATERIALS AND METHODS 
D.6 deoxy Ins(1,4,5)P~, D.6-~eoxy-lns(t ,2-¢ychc-4,S)l)~ and 
D.6 deo~y-lns(l,5)Pz were prepared by total synthes~s from D- 
galactose (D Dubreutl, J Cl¢ophax, B V L Potter and S.D Gero, 
manuscript m preparation) Full d~'tads of the synthetic procedures 
w~ll be reported elsewhere D.myo.mositol 1,4,S-tnsphosphoro. 
thloat¢ (D-Ins(l,4,5)PS~) was syntheszzed and purified s=mdarly to 
the procedu-e described for racemtc material [I01 D-Ins(l,4,S)Pa was 
from Calbiochem All cell culture reagents were from G1bco 4SCaCl2 
(approx I000 C~/mmol) was from Amersham International ECso 
~a[ues were derived using ALLF[T computer-asslsted curve fltung 
[18] Combined data from a number of Independent experiments (n) 
are expressed as mean ± SEM, where n >_. 3 
2 1 Ca ~" release 
4sCa2" release xperiments were carried out ¢s,entlally as described 
[1910 but using saponm-permeablh~ed SH°SYSY neuroblastoma celh 
[17] Temporal charactensucs of Ca 2÷ mobfllsatlon were momtored 
using a CaZ'.specff,c electrode [20] 
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( l l  D.In~tl,4,~)P) arid O) 
D.(s,de~y.lmf1,4,~l)P, 
2, -~, In~t I, 4,$]P~ .~.phmph#m~¢ 
Inhlbillon by 6.d¢o~y.lnt(I,4,.~)P~ of human erythrc~He ahml 
$,photphatase,~a(~l~'ted breakdown or ;ll'~Pl,lnstl,4,~)P~ w~ ex, 
~mined ¢~tentlally ~tde)¢rlll~d rot m.~o.ino)ilol 1,4,$.trhphosphoro. 
thlo#te (21) Erythroey|~ llho)t~ (I roll proletn/ml) were in<ub~¢,ed ~t¢ 
~,?'C ror IJ ndn in the pre~en¢e of .~0/~M Int(l,4,!i}P) (=tppro~ 
J000 dpm ~l.[;=P].lnt(l,4,~)P0 ~nd 0=1 mM 6.dcc~y.lnffl,4,~)P) 
Under ~he~e ¢ondhlom no more ~han 20% of hB(I,4,~)P) ~.~ ~o.. 
~umed To asaerlaln whe, ther 6.deoxy.lnff 1,4,$)P) ~va) ~ ~ub~lr~|¢ ror 
J.phosphntase, In~(I,4,~)P) (40 ,.M), 6.deoxy.ln~(I,4.~)P~ (Is0 pM) 
or KHaPO~ (0-$0/~M) were incuba|ed with erylhroayle IlhOMt 
(I mlllml) at 37'C for 30 rain, Inorsanl~ phosphe~e aBay to deler. 
mine phosphale released was c~rtled out ,~ described llll, 
2 ~ inafl,4,$)Ps 3./~t~m~¢ 
Inh~bi|ion or l)H].lns(I,4,$)P) phosphorylalmn by Gdeox). 
Int(I,4,S)P= was examined by incuhatmil a ,.rude- ).kinase prepara. 
don (1"/] (0,1o'. w/v) nt 3"/'C m the presence of 3, 10 or ]0/~,t 
In~(I,4,~)P=, ~=, 10000dpm [)HJ.lnz(I,4,S)P) and Inereaslnli 
amounts of 6.deo~,.lns(I,4.$)P) under ¢ondztmm where no more 
Ihan 20Vo of [ns(1,4,5)P~ az phosphorylated, Mono., his., (ris- nnd 
(etrakzsphospha(e fra¢tmns ~ere separated using =on excl)an=e 
chromatography on Dow¢,~ AGI.X8 resin [22] Rates of 
[ns(I,3,4,S)Pa fornlaltOn ~ere then ,.ah.ulaled 
3. RESULTS AND DISCUSSION 
Only 4 studies concerned with biolog=caI activity of 
n,zg-modified analogues of Ins(l,4,5)P~ have been 
reported [13-16]. An interesting aspect concerns the 
potential role of the 6.hydroxyl group of Ins(l,4,5)P~, 
adjacent to the crucial victual 4,5-bisphosphate, m
determtmng the affimty and specificity of Ins(l,4,S)Pz 
for ~ts mtracellular receptor and its mteractmn with the 
metabohc enzymes Ins(1,4,5)Ps 3-kmase and 
5-phosphatase. We have examined this by deleting the 
6-hydroxyl group of Ins(1,4,5)Ps. 6-deoxy-lns(1,4,J)Pz 
has previously been chemically synthesized by a dif- 
ferent route to our procedu=e [13] and other 6.modified 
analogues whzch have been synthesized include 
6.methoxy-Ins(1,4,5)P~ [13,14], 6-methyl-Ins(l,4,5)P~ 
[13] and 6-fluoro-lns(l,4,5)Pz [13]. However, only 
6-methoxy-Ins(1,4,5)P~ has been biologically evaluated 
and found to be a weak agonist [14]. Apart from a 
study of the effects of muluple hydroxyl group deletion 
of Ins(l,4,5)Pz on biological activity [14], the only 
other similar investigations already reported cor~cern 
hydroxyl group deletion m myo-inositol -phosphate 
(Ins(1)P), a substrate for inositol l-phosphatase. 
6-Deoxy-myo-inositol l-phosphate is a compet=t~ve in-
hibitor of myo-mositol l.phosphatase [23] and 
3,$,6.tfl~d¢oxy.myo.ino~itol I.pho~phat¢ h the meal 
potent inhibitor yet identified [241. 
The EC),, for lm(I,4,5)PPindu¢¢d Ca ~" release in 
permeabtllsal SH..~YgY human neuroblasloma cell~ 
wn~ 0,09 ~ 0.02,~M (Fill. 2). For D.6.deo~y. 
lns(I,4,S)P) (2) |he EC~,~ was 6.4 ± !,7 ~.M (Fii!, 2) and 
the analogue wa~ # full agonist for C~ J" release Thu~, 
deletion of the 6.hydroxyl group make~ the analo|u¢ 
approximately ?0.fold les~ potent ~h~n lns(l,4,S)P~, 
The(e dAt;t sUilgeSt that 6-deoxy-lns(I,43)P~ has a 
lower affiniw than lns(I,4,~;)P~ for the Ca~'-releasins 
tee©peer. This has been confirmed by radioligand 
binding to rat aerebellnr receptors (A ,L ,  Wil l¢oaks, 
B.V.L. Potter and S.R. N~horski, data not ,~hown), 
where the IC~o for 6-deoxy-in~(l,4,~)P~ in displacing 
bound [)H].lns(l,4,5)P) was 6/~M (for comparison, 
the lC~o for lns(l,4,S)P~ was 60 nM), The related syn- 
thetic compound, D.6-deoxy (t,2-cyclic).myo-mositol 
4,$-trisphosphate, had an IC~o of 40/~M (for com- 
parison, the lC~o for D-Ins(I,2-¢y¢lic.4,S)P~ was 
2.~pM). Synthetic D-6-deoxy-myo-inositol t,5-bis- 
phosphate ~howed no detectable d~splacement up to 
100~M, 
In contrast, only a small decrease in Ca=*-releming 
potency was observed upon deletion of the 2-hydroxyl 
group of Ins(t,4,5)P~. The ECho for DL-2-deoxy- 
lns(l,4,~)Ppinduced Ca ~° release m permeabd~sed 
macrophages was 0,5/~M, whereas that for 
Ins(l,4,5)Pa was 0,2/=M [15]. Mult=ple deletion of 
hydroxyl groups to produce 1,2,4.cyclohexane 
trisphosphate was shown to lead ¢o substantial loss of 
potency (ca 130-fold for racemtc material) [14] 
3-Deoxy-lns(l,4,5)P~ has not yet been synthesized, 
DL-6-Methoxy-lns(l,405)P~ was ca 200-fold weaker 
than Ins(l,4,5)Pa m mob,l~smg Ca ~+ [14]. 
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Fig 2 Dose-dependence of 4SCaZ+ releasing effects of Ins(l,4.5)P~ 
(o) and D-6-deoxy-lns(1,4,5)P~ (el m permeablhsed SH-SYSY cells 
Saponm.permeabihsed SH-SY5Y cells were loaded with 4Sea'+ and 
then challenged ~zth agomst Incubations at 20°C were terminated 
after 2 ram, at wh,ch point the amount of 4SCa2* released was 
assessed as described m Sectlon 2 (lns(l,4,5)P3, n = 6, 6-deoxy- 
lr, s(l,4,5)P3, n = 3) 
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The three nesaflvely ~hatlled phosphate llroup~ of' 
Ins(I,4,S)P~ will most likely make ionic [nteraetlon~ 
with appropriate positive centres of the lm(I,4,S}P~ 
receptor and make the major contribution to bindinm 
enerly, The three hydroxyl iiroup,~ a¢ )he 2, 3 and 6 
positions ma~, be either hydrosen bond donors to, or 
accepters from the protei~ and, additionally, they may 
be involved in fixln~ the solution conformation of 
ins(l,4,~)P~ by intramolecular hydrolen bondinll to 
n¢ishbourinil phosphate iiroups. The vicinal 
D-4,S-bisphosphate system is known to be essential for 
CaZ*.releaslng activity, while the l-phosphate enhances 
receptor bindinii [9], Therefore, removal oi' the 
6-hydroxyl 8reap, a neighbour to both the i- and the 
~-phosphate groups, may affect the conformation of 
these phosphates and the population or appropriate 
conformer for receptor bindlna, No data are, however, 
yet available concerning the conformation of 
[ns(l,4,$)Ps bound to its receptor, 
Ins(l,4,S)P~ is metabohsed by two m~or routes that 
involve, as the first step, dephosphorylation by a 
S-phosphatase and phosphorylation by a 3-kinase [9]., 
The metabohsm of 6-d¢oxy-lns(t,4,5)P) was examined 
(a) 
6,0 ' 
pCa 
6,5 
3gM ~O0pM 
Ins(1 4 5)P 3 60eoxy Ins(1 4 5)P 3 
initially uslnll el~trically-permeabllLted $H-SYSY celh 
and conflnuoul monltodnll of Ca I" release, £H.~YSY 
rolls ¢~hibit bmh lns(l,4,S)P~ ~l.phosphalase and 
:l-kinas¢ activities (2S). The Ca =" rel~ts¢ profile rot 
6.deoxy.ins(I,4,~;)P~ differed from |hat exhibited by 
Ins(I,4,S)P~ (Fillt. 3a) Insofar as Ca z. rc.gptake, and 
therefore Inod~ol phnsphate mettboli~m [20], appeared 
to be sillnificantly retarded. This re.uptake was, 
however, faster than that for the non.hydrolysable 
analoilue lns(l,4,S}PS~ [9] (Fill. 3b), which is resistant 
to metabolism by both 5-phosphatase and 3-kanaka 
[9,21,2J]. Thus, 6.deoxy.lnt(I,4,S)P~ may be 
metabolised slowly by one or both or the enzymes, 
We therefore investisated the interaction of 
D.6.de,..xy.lns(I,4,~;)P~ witl~ [ns(l,4,5)P~ 5.phos. 
phatas¢ from human erythrocyte ghosts, D.6-deoxy. 
ins(1,4,S)P~ inhibited [~=P]tns(l,4,S)P~ dephosphoryla. 
tion with a K, of 76,0 ± 5,2 I~M (Fit. 4), Since the K,. 
for D-[ns(I,4,S)P~ is ca 40pM [21], D.6.deoxy. 
[ns(l,4,5)P= clearly binds with relatively high affinity 
to the $.phosphatase. The approx=mately 2-fold weaker 
affinity of 6-deoxy-[ns(l,4,~)P= for erythrocyte 
S-phosphatase underlines the marked non-selectivity of 
this enzyme for inos=to[ phosphates, as previously 
noted [4,9], and is comparable w=th the approximately 
4-fold lower affinity of DL-6-methoxy-lns(l,4,S)P~ for 
the aortic smooth muscle enzyme [14]. D.6-deoxy- 
[ns(l,4,5)P~ was, however, reststant o dephosphoryla- 
tion by Ins(l,4,5)P~ S.phosphatase, since inorganic 
phosphate was not liberated after a 30 man incubation 
with the enzyme under conditions where 40°'/0 of 
lns(l,4,5)P= was hydrolysed (data not shown) This is 
tn agreement w=th the conclus=on of' Polokoff et a[, [14] 
that the mammal structural requzrements for substrata 
hydrolysis by 5-phosphatase include phosphate groups 
at the D-4,S-positions and a free D-6-hydroxyl group 
a,o, I
pCa 
6,S 
(b) 
& • 
3}~t,,1 25~M 
tns(~4q)P3 I ns (145)pS  3 
10 mi l l ,  
Fig 3 Kmeucs of Ca 2. release mduced by D-Ins(l,4,5)Ph 6-deoxy 
tns(1,4,5)P~ and Ins(1,405)P$3 momlored in SI--I-SY 5 Y 
neuroblastoma cells using a Ca2"-specff, c electrode Suspensions of 
electncally-permeab|lised SH-SYSY cells (3 6-3.9 mg prote in / ro t )  
were challenged wlth (a) 3/~M Ins(l,4,5)P~ followed by 100/~M 
6.deoxy-lns(l,4,5)Pz, or (b) 3pM tnstl,4,~)P3 followed by 25.aM 
Ins(l,4,5)PS3 Data shown are representatlve of 3 mdep0ndem 
experiments 
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Fig 4. Inhlbluon of human erythrocyte Ins(l,4,S)P~ 5-phosphatase- 
catalysed dephosphorylat[on f [a=P]Ins(l,4,5)P~ by D 6-deox~- 
Ins(l,4,5)Pz (el and DL-Ins(I,4,5)PS3 to) Ins(l,4,5)P~ (30/~M) 
containing ca I0000 dpm 5-[~2P]Ins(l,4.5)Pa w s incubated at 37°C 
for 15 mm wlth 5-phosphatase and0 1/~M-I rnM Ins(l,4,5)PS~, or 
6-deoxy-lns(l,4,5)P: (n = 3) The rate or hberauon of inorganzc 
[32p]phosphate was rnonztored as described [21] Ki values were 
calculated according to Chang and Prusoff [26]. 
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Fill. ~,, Dl~on plot ,=l~o,*htl~ ,:ompetltlv¢ Inhthhlon of la,(I,4,~lm+ 
:l.kina,l¢.~:atl, ly~¢d pho~phor)tlatlon of D.In,(1.4,~]Pz by D,6.d¢o.~,. 
In,t(I,,t,,+,)P,. V~ri~uz ¢on,r=ntratloo,, or Ins(I,4,f,)Ps (3/+M (D). 
10/~hl (~) ~nd ~O,aM (.~)) were meubaled at 311'C for I~ nlln witl~ 
the Ins(i,4J)P~ ..l.kinaw preparation (0.1% w/v) and 0=.~00.~M 
6.deo,q,,hts(I,4,$)P~ (~ - ~16], The rate of formation or 
Ins(I,~l,4,5)P, was mofltlored as de,at=bed m Section 2 
the 3.kina.~e and ttli~ explains tile 5low re.uptake of 
Ca a. ~s seen in Fie, 3a, 
%'¢ ¢on¢lutl¢ that the 6-hydroxyl group of 
Ins(1,4,S)Ph while not absolutely required for t|imula. 
alan of Ca ~" release, is probably Important In ~eeeptor 
bindin| or fixinl/, the conformation of nellhbourinl 
phospha[e groups, to a significantly gre~ter extent than 
the 2-hydroxyl group. Clearly, hydroxyl group deletion 
remote from the 3.hydroxyl site does not markedly or- 
feet affinity for the 3.ki~ase, Indeed, 6.deoxy- 
lns(I,4,5)P~ may be a weak subs(rate for this enzyme, 
Hydroxyl dolor=on adjacent to the S-phosphate group, 
however, makes 6-deoxy.lns(I,4,5)P, a relatively po- 
tent 5,phosphatase inhibitor. 
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